title: GLP-1 agonist treatment: implications for diabetic retinopathy screening.
abstract: Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.
authors: Department of Diabetes and Endocrinology, University Hospital of North Staffordshire NHS Trust, Springfield Unit, North Buildings, Stoke-on-Trent ST4 6QG, United Kingdom.
authors: Lakshminarayanan
authors: L
authors: Varadhan
authors: Tracy
authors: T
authors: Humphreys
authors: Christian
authors: C
authors: Hariman
authors: Adrian B
authors: AB
authors: Walker
authors: George I
authors: GI
authors: Varughese
mesh_terms: D000328:Adult; D000368:Aged; D048909:Diabetes Complications / Q000175:diagnosis / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000819:agonists* / Q000627:therapeutic use*; D006801:Humans; D007332:Insulin Infusion Systems; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000175:diagnosis* / Q000209:etiology; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D052216:Glucagon-Like Peptide 1